Treatment of hepatitis B virus-related polyarteritis nodosa: Two case reports and a review of the literature

Clinical Rheumatology

Volumn 23, Issue 2, 2004, Pages 172-176

  Deeren, Dries H ^a   De Backer, A I ^b   Malbrain, M L N G ^a   Verbraeken, H ^a   Blockmans, D ^c  

^a Algemeen Centrumziekenhuis Antwerpen ^*  (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Corticosteroids; Hepatitis B; Lamivudine; Plasma exchange; Polyarteritis nodosa

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; CARVEDILOL; COCAINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DIAMORPHINE; EARLY ANTIGEN; ENALAPRIL; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; INTERFERON; LAMIVUDINE; LISINOPRIL; METHYLPREDNISOLONE; PREDNISONE; VIDARABINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN INFARCTION; CASE REPORT; CAUSE OF DEATH; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG WITHDRAWAL; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LUNG EDEMA; MALE; MORTALITY; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RELAPSE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FATAL OUTCOME; GLUCOCORTICOIDS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLASMA EXCHANGE; POLYARTERITIS NODOSA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT REFUSAL;

EID: 2342430224     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0857-4     Document Type: Article

References (22)

1. Trepo C, Guillevin L (2001) Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 16: 269-274
2. Guillevin L, Lhote F, Jarrousse B et al. (1992) Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients. Ann Med Interne (Paris) 143 Suppl 1:63-74
3. McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP (1989) Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 9:97-101
4. Guillevin L, Mahr A, Cohen P et al. (2003) Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2003 (in press)
5. Guillevin L, Lhote F, Cohen P et al. (1995) Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74:238-253
6. Guillevin L, Lhote F, Leon A, Fauvelle F, Vivitski L, Trepo C (1993) Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol 20:289-298
7. Guillevin L, Lhote F, Sauvaget F et al. (1994) Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 53:334-337
8. Avsar E, Savas B, Tozun N, Ulusoy NB, Kalayci C (1998) Successful treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha as first-line therapy. J Hepatol 28:525-526
9. Simsek H, Telatar H (1995) Successful treatment of hepatitis B virus-associated polyarteritis nodosa by interferon alpha alone. J Clin Gastroenterol 20:263-265
10. Mouthon L, Deblois P, Sauvaget F, Meyrier A, Callard P, Guillevin L (1995) Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy. Am J Nephrol 15:266-269
11. Lam KC, Lai CL, Trepo C, Wu PC (1981) Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 304:380-386
12. Wood JR, Czaja AJ, Taswell HF, Ludwig J, Rakela J, Chase R (1987) Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B. Gastroenterology 93:1225-1230
13. Chiaramonte M, Floreani A, Martines D, De Lazzari F, Naccarato R (1982) Hepatitis B virus infection and cyclophosphamide. Ann Intern Med 97:451-452
14. Trepo C, Ouzan D, Delmont J, Tremisi J (1988) Superiority of a new etiopathogenic treatment curing periarteritis nodosa caused by hepatitis B virus, using a combination of brief corticotherapy, vidarabine and plasma exchange (in French). Presse Med 17:1527-1531
15. Schalm S, De Man R, Janssen H (2002) Combination and newer therapies for chronic hepatitis B. J Gastroenterol Hepatol 17 Suppl 3:S338-S341
16. Perrillo RP (2000) Short-term corticosteroid therapy in combination with lamivudine: A case of deja vu? Hepatology 32:663-665.
17. Liaw YF, Tsai SL, Chien RN, Yeh CT, Chu CM (2000) Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B. Hepatology 32:604-609
18. Zarski JP, Causse X, Cohard M, Cougnard J, Trepo C (1994) A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group. J Hepatol 20:735-741
19. Dienstag JL, Schiff ER, Wright TL et al. (1999) Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341:1256-1263
20. Leung NW, Lai CL, Chang TT et al. (2001) Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33:1527-1532
21. Guillevin L, Lhote F, Cohen P et al. (1995) Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum 38:1638-1645
22. Guillevin L, Fain O, Lhote F et al. (1992) Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 35:208-215